A world of possibilities
Navigating life sciences and medtech to the extraordinary—driven by creativity, curiosity, and the courage to build a fulfilling journey.
-
Pharmaceutical compositions for the treatment of cystic fibrosis transmembrane conductance regulator‑mediated diseases
What This Patent Covers This patent claims combination pharmaceutical compositions that treat Cystic Fibrosis Transmembrane Conductance Regulator (CFTR)‑mediated diseases — most importantly, cystic fibrosis (CF) — by administering an effective amount of a combination of…
-
Sugar derivatives and uses thereof to prepare novel senolytic agents
Patent Number: US 11,897,915 B2Filing Date: January 3, 2024Publication/Issue Date: June 6, 2024Assignee: Rubedo Life Sciences, Inc.Inventors: Paul Keitz, Gus Bergnes, Mark A. Gallop, Marco Quarta What This Patent Covers Overview:This granted patent protects a new class of sugar‑derived chemical compounds…
-
Optimized CSP Variants and Related Methods
What This Patent Covers This international patent application claims optimized variants of the CSP protein (likely referring to a circumsporozoite protein or another clinically relevant antigen candidate, depending on BioNTech’s vaccine or therapeutic focus) and…
BioTech IP Review 